Patent Yard Sign in
Expired Canadian patentCanada

Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof

CA 2521648 C · Owner: Iwakami, Noboru · Inventors: Iwakami, Noboru; Kimura, Tatsuo; Saitoh, Akihito

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

An alkyl ether derivative represented by the following general formula 1, (see formula 1) or its salt: wherein R1 and R2 represent each a substituent such as hydrogen, halogeno or alkyl; R3 represents alkylamino, amino or hydroxyl; the ring A represents a 5- or 6-membered aromatic heterocycle or a benzene ring; m and n are each an integer of from 1 to 6; and p is an integer of from 1 to 3; shows an effect of protecting retinal nerve cells and, therefore is , useful as a preventive and/or a remedy for retinal nerve diseases such as glaucoma, diabetic retinopathy retinal artery obstruction, retinal venous obstruction macular degeneration and retinopathy of prematurity.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 15, 2004 and granted July 3, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 15, 2024.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 15, 2026.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 15, 2004
GrantedJuly 3, 2012
Term endedApril 15, 2024
Patent numberCA 2521648 C
Classification (IPC)A61K31/39 +2 more

Timeline

Timeline From CIPO dates

2005200720092011201320152017201920212023Application filedApril 15, 2004Patent grantedJuly 3, 2012Term endedApril 15, 2024

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.